Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barth

Showing results (301-310 of 400) with videos related to

Pageof 40
Sort By:
The Journal of Rheumatology|September 1, 1982
Human lymphocyte antigens characterizing psoriatic arthritis and its subtypesL H Gerber, C L Murray, S G Perlman, et al.
Life Sciences|January 1, 1995
Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonistM Rinaldi-Carmona, F Barth, M Héaulme, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 19, 2015
Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumorsRolf F Barth, Weilian Yang, Robin J Nakkula, et al.
Cancer Biology & Therapy|August 26, 2006
Differentiation of normal skin and melanoma using high resolution hyperspectral imagingDavid T Dicker, Jeremy Lerner, Pat Van Belle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4Weilian Yang, Rolf F Barth, Gong Wu, et al.
American Journal of Clinical Pathology|May 9, 2000
Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donorT E Gorman, C J Julius, R F Barth, et al.
Journal of the Air & Waste Management Association (1995)|December 6, 2012
Evaluation of a sustainable remediation option: beneficial reuse of petroleum-contaminated sediment as an energy sourceAdison Sasivongpakdi, Joo-Youp Lee, Hari Bharadwaj, et al.
Cancer Research|September 3, 2004
Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumorsRolf F Barth, Weilian Yang, Ashraf S Al-Madhoun, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 15, 2006
3-Carboranyl thymidine analogues (3CTAs) and other boronated nucleosides for boron neutron capture therapyYoungjoo Byun, Sureshbabu Narayanasamy, Jayaseharan Johnsamuel, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 16, 2011
Comparison of intracerebral delivery of carboplatin and photon irradiation with an optimized regimen for boron neutron capture therapy of the F98 rat gliomaRolf F Barth, Weilian Yang, Tianyao Huo, et al.
Pageof 40

Showing results (301-310 of 400) with videos related to

Sort By:
Pageof 40
The Journal of Rheumatology|September 1, 1982
Human lymphocyte antigens characterizing psoriatic arthritis and its subtypesL H Gerber, C L Murray, S G Perlman, et al.
Life Sciences|January 1, 1995
Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonistM Rinaldi-Carmona, F Barth, M Héaulme, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 19, 2015
Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumorsRolf F Barth, Weilian Yang, Robin J Nakkula, et al.
Cancer Biology & Therapy|August 26, 2006
Differentiation of normal skin and melanoma using high resolution hyperspectral imagingDavid T Dicker, Jeremy Lerner, Pat Van Belle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4Weilian Yang, Rolf F Barth, Gong Wu, et al.
American Journal of Clinical Pathology|May 9, 2000
Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donorT E Gorman, C J Julius, R F Barth, et al.
Journal of the Air & Waste Management Association (1995)|December 6, 2012
Evaluation of a sustainable remediation option: beneficial reuse of petroleum-contaminated sediment as an energy sourceAdison Sasivongpakdi, Joo-Youp Lee, Hari Bharadwaj, et al.
Cancer Research|September 3, 2004
Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumorsRolf F Barth, Weilian Yang, Ashraf S Al-Madhoun, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 15, 2006
3-Carboranyl thymidine analogues (3CTAs) and other boronated nucleosides for boron neutron capture therapyYoungjoo Byun, Sureshbabu Narayanasamy, Jayaseharan Johnsamuel, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 16, 2011
Comparison of intracerebral delivery of carboplatin and photon irradiation with an optimized regimen for boron neutron capture therapy of the F98 rat gliomaRolf F Barth, Weilian Yang, Tianyao Huo, et al.
Pageof 40